OURA CEO Tom Hale tries to set a record directly about smart ring manufacturers partnership The Department of Defense (DOD) and data miner Palantir, used by defense, intelligence and law enforcement agencies in the United States and elsewhere. In wealth Brainstorming technology At Monday’s meeting, Hale’s interview began, and he completely denied that the company was sharing user data with the government.
“There is a lot of misinformation about this,” he said, referring to numerous influencer-driven reports that led to a virus rebound to health trackers. OURA’s ring collects information about users’ heart rate, sleep, body temperature, exercise, menstrual cycle, and more.
Hale has addressed misleading reports and subsequent PR backlash online to assure users His first Tiktok Video “The company has not sold the data to third parties without your explicit consent.
Instead, he explained that the DOD program was involved in the DOD program, requiring the company to run its enterprise solutions in a separate, secure environment, and that the government has no access to users’ OURA health data.
Hale reiterated these views on Monday, saying: “For the sake of record, we will never share your data with anyone unless you instruct us to do so. We will never sell your data to anyone.” He said the reports circulating online said that ORA’s cooperation with the U.S. government to share user data was “basically incorrect” and he was grateful that the anger began to calm down.
Additionally, he tried to dispel confusion over the company’s relationship with Palantir, calling it a “partnership” “a bit of a sell-off.”
Instead, Hale explained that OUA acquired a company last year that had a SaaS (Software Services) relationship with Palantir – meaning a commercial contract, not a data sharing agreement. This relationship is targeted at the so-called impact level 5 or IL5, which is the DOD certification standard for processing sensitive, unclassified data.
TechCrunch Events
San Francisco
|
October 27-29, 2025
“This is an integral part of their solution. The contract is still running, and this relationship – relationship – a “massive partnership” with Palantir blows up… We don’t have smaller business relationships. The system is not connected. Palantir cannot access your data. No one in the government can see your data. No one on Palantir can see your data.
Hale added that the privacy and security of user data are important to the company and its customers. He also noted that OURA’s terms of service state that it will object to any efforts designed to use user data for monitoring or prosecution purposes. He even pointed out that when users authorize OURA to check their data (for example, for technical support purposes), the review has limited role in the company and can only be viewed specifically with authorized content.
“We don’t look at people’s data… you can’t do that,” he said.
The CEO also briefly addressed Oura’s future, observing that the market is shifting, especially in Asia and India, to smaller, cheaper wrist wearables. Meanwhile, the size of the ring wearable device has doubled.
“We are growing 100% north,” Hale noted.
The company sees its potential as a health device that becomes “preventive” that reminds users of the problem before they become the problem that makes them sick. This is helped by facts designed to make users aware of how their health metrics develop. The company also leverages machine intelligence and provides dedicated health consultants.
OURA does see itself working with the government, not affecting the way influencers describe it. Hale said the company partnered with Medicare Advantage to provide rings for qualified patients.
Hale also hints at the possibility of other wearable devices.
“It’s really cool if there’s a ring that can rule all of this, but we actually know it’s not true,” he said. [W]This is a metabolism [monitoring]maybe it’s blood pressure, maybe it’s activity, maybe it’s something else – maybe it’s other types of indicators. So, I am very confident that we will see a bunch of wearables. Moreover, the choice of these wearable devices will be related to the clinical use you are trying to use. ”
